Glycaemic outcomes, including insulin resistance, prediabetes (impaired fasting glucose) and type 2 diabetes, were assessed using fasting glucose and insulin (ages 7, 15, 18 and 24 years) and HbA<sub>1c</sub> (age 9 years). This evidence concerns the gene INS and type 2 diabetes mellitus.